isoproterenol and thalidomide

isoproterenol has been researched along with thalidomide in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Botting, JH1
Arya, DS; Kishore, K; Kumari, S; Loh, HK; Nag, TC; Ray, R; Sahoo, KC1
Cachofeiro, V; Davel, AP; De Sá, LL; Fukuda, LE; Lahera, V; Munhoz, CD; Rossoni, LV; Sanz-Rosa, D; Scavone, C1

Reviews

1 review(s) available for isoproterenol and thalidomide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for isoproterenol and thalidomide

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Animal research. Various fallacies persist in vivisection debate.
    BMJ (Clinical research ed.), 2001, Jun-30, Volume: 322, Issue:7302

    Topics: Abnormalities, Drug-Induced; Animal Welfare; Animals; Bronchodilator Agents; Drug Evaluation, Preclinical; Humans; Isoproterenol; Teratogens; Thalidomide

2001
Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study.
    Basic & clinical pharmacology & toxicology, 2007, Volume: 100, Issue:4

    Topics: Administration, Oral; Animals; Blood Pressure; Dose-Response Relationship, Drug; Endocardium; Heart; Heart Injuries; Heart Rate; Immunosuppressive Agents; Injections, Subcutaneous; Isoproterenol; Male; Microscopy, Electron, Transmission; Mitochondria, Heart; Myocardium; Myofibrils; Rats; Rats, Wistar; Thalidomide; Ventricular Function, Left; Ventricular Pressure

2007
Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:1

    Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Aorta; Blotting, Western; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Hemodynamics; I-kappa B Proteins; Inflammation Mediators; Injections, Subcutaneous; Interleukin-1beta; Interleukin-6; Isoproterenol; Male; NF-KappaB Inhibitor alpha; Oxidative Stress; Phenylephrine; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Salicylate; Superoxide Dismutase; Thalidomide; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents

2008